Novel mutations introduced at the beta-site of amyloid beta protein precursor enhance the production of amyloid beta peptide by BACE1 in vitro and in cells.
JOURNAL OF ALZHEIMERS DISEASE(2005)
摘要
Abnormal production and accumulation of amyloid-beta peptide (A beta) plays a major role in the pathogenesis of Alzheimer's disease (AD). beta-secretase (BACE1) is responsible for the cleavage at the beta-site in amyloid beta protein precursor (A beta PP/APP) to generate the N-terminus of A beta. Here we report the stepwise identification and characterization of a novel APP-beta-site mutant, "NFEW (APP-NFEV) in vitro and in cells. In vitro, the APP_NFEV exhibits 100-fold enhanced cleavage rate relative to the "wild-type" substrate (APPwt) and 10-fold increase relative to the Swedish-type mutation variant (APPsw). In cells, it was preferably cleaved among 24 APP beta-site mutations tested. More importantly, the APP_NFEV mutant failed to generate any detectable A beta peptides in BACEI-KO mouse fibroblast cells. The production of A beta peptides was restored by co-transfecting human BACE1, demonstrating that BACE1 is the only enzyme responsible for the processing of APP-NFEV in these cells. Analysis of APP_NFEV cleavage products secreted in the media revealed that in cells BACE I cleaves APP-NFEV at the position between NF and EV, identical to that observed in vitro. A BACE inhibitor blocked the processing of the APP_NFEV beta-site in vitro and in cells. Our data indicates that the "NFEW mutant is not only an enhanced substrate for BACE1 in vitro, but also a specific substrate for BACE1 in cells.
更多查看译文
关键词
Alzheimer's disease,BACE,beta-secretases,APP
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要